Oral Vaccines Industry Research Report 2024
Summary
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, the global Oral Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, the global Oral Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Oral Vaccines Sales (2019-2030)
2.2.3 Global Oral Vaccines Market Average Price (2019-2030)
2.3 Oral Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Rotavirus Vaccine
2.3.3 Cholera Vaccine
2.3.4 Oral Polio Vaccine
2.4 Oral Vaccines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Public
2.4.3 Private
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Oral Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Oral Vaccines Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Oral Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global Oral Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global Oral Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oral Vaccines, Product Type & Application
3.8 Global Manufacturers of Oral Vaccines, Date of Enter into This Industry
3.9 Global Oral Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Oral Vaccines Product Portfolio
4.1.5 Merck Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Oral Vaccines Product Portfolio
4.2.5 GSK Recent Developments
4.3 Sanofi
4.3.1 Sanofi Company Information
4.3.2 Sanofi Business Overview
4.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sanofi Oral Vaccines Product Portfolio
4.3.5 Sanofi Recent Developments
4.4 Lanzhou Institute
4.4.1 Lanzhou Institute Company Information
4.4.2 Lanzhou Institute Business Overview
4.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
4.4.5 Lanzhou Institute Recent Developments
4.5 Serum Institute
4.5.1 Serum Institute Company Information
4.5.2 Serum Institute Business Overview
4.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Serum Institute Oral Vaccines Product Portfolio
4.5.5 Serum Institute Recent Developments
4.6 Valneva
4.6.1 Valneva Company Information
4.6.2 Valneva Business Overview
4.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Valneva Oral Vaccines Product Portfolio
4.6.5 Valneva Recent Developments
4.7 Shanghai United Cell
4.7.1 Shanghai United Cell Company Information
4.7.2 Shanghai United Cell Business Overview
4.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
4.7.5 Shanghai United Cell Recent Developments
4.8 Bibcol
4.8.1 Bibcol Company Information
4.8.2 Bibcol Business Overview
4.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Bibcol Oral Vaccines Product Portfolio
4.8.5 Bibcol Recent Developments
4.9 PaxVax
4.9.1 PaxVax Company Information
4.9.2 PaxVax Business Overview
4.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 PaxVax Oral Vaccines Product Portfolio
4.9.5 PaxVax Recent Developments
4.10 Vabiotech
4.10.1 Vabiotech Company Information
4.10.2 Vabiotech Business Overview
4.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Vabiotech Oral Vaccines Product Portfolio
4.10.5 Vabiotech Recent Developments
4.11 Tiantan Biological
4.11.1 Tiantan Biological Company Information
4.11.2 Tiantan Biological Business Overview
4.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Tiantan Biological Oral Vaccines Product Portfolio
4.11.5 Tiantan Biological Recent Developments
4.12 EuBiologics
4.12.1 EuBiologics Company Information
4.12.2 EuBiologics Business Overview
4.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.12.4 EuBiologics Oral Vaccines Product Portfolio
4.12.5 EuBiologics Recent Developments
4.13 Panacea Biotec Ltd
4.13.1 Panacea Biotec Ltd Company Information
4.13.2 Panacea Biotec Ltd Business Overview
4.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
4.13.5 Panacea Biotec Ltd Recent Developments
4.14 Bio-Med
4.14.1 Bio-Med Company Information
4.14.2 Bio-Med Business Overview
4.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Bio-Med Oral Vaccines Product Portfolio
4.14.5 Bio-Med Recent Developments
4.15 Halfkin Bio-Pharmaceuticals
4.15.1 Halfkin Bio-Pharmaceuticals Company Information
4.15.2 Halfkin Bio-Pharmaceuticals Business Overview
4.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
4.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
5 GLOBAL ORAL VACCINES MARKET SCENARIO BY REGION
5.1 Global Oral Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Oral Vaccines Sales by Region: 2019-2030
5.2.1 Global Oral Vaccines Sales by Region: 2019-2024
5.2.2 Global Oral Vaccines Sales by Region: 2025-2030
5.3 Global Oral Vaccines Revenue by Region: 2019-2030
5.3.1 Global Oral Vaccines Revenue by Region: 2019-2024
5.3.2 Global Oral Vaccines Revenue by Region: 2025-2030
5.4 North America Oral Vaccines Market Facts & Figures by Country
5.4.1 North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Oral Vaccines Sales by Country (2019-2030)
5.4.3 North America Oral Vaccines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Oral Vaccines Market Facts & Figures by Country
5.5.1 Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Oral Vaccines Sales by Country (2019-2030)
5.5.3 Europe Oral Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Oral Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific Oral Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Oral Vaccines Market Facts & Figures by Country
5.7.1 Latin America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Oral Vaccines Sales by Country (2019-2030)
5.7.3 Latin America Oral Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Oral Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Oral Vaccines Sales by Type (2019-2030)
6.1.1 Global Oral Vaccines Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Oral Vaccines Sales Market Share by Type (2019-2030)
6.2 Global Oral Vaccines Revenue by Type (2019-2030)
6.2.1 Global Oral Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global Oral Vaccines Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Oral Vaccines Sales by Application (2019-2030)
7.1.1 Global Oral Vaccines Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Oral Vaccines Sales Market Share by Application (2019-2030)
7.2 Global Oral Vaccines Revenue by Application (2019-2030)
7.2.1 Global Oral Vaccines Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
7.3 Global Oral Vaccines Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Oral Vaccines Value Chain Analysis
8.1.1 Oral Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oral Vaccines Production Mode & Process
8.2 Oral Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oral Vaccines Distributors
8.2.3 Oral Vaccines Customers
9 GLOBAL ORAL VACCINES ANALYZING MARKET DYNAMICS
9.1 Oral Vaccines Industry Trends
9.2 Oral Vaccines Industry Drivers
9.3 Oral Vaccines Industry Opportunities and Challenges
9.4 Oral Vaccines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Oral Vaccines Sales (2019-2030)
2.2.3 Global Oral Vaccines Market Average Price (2019-2030)
2.3 Oral Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Rotavirus Vaccine
2.3.3 Cholera Vaccine
2.3.4 Oral Polio Vaccine
2.4 Oral Vaccines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Public
2.4.3 Private
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Oral Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Oral Vaccines Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Oral Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global Oral Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global Oral Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oral Vaccines, Product Type & Application
3.8 Global Manufacturers of Oral Vaccines, Date of Enter into This Industry
3.9 Global Oral Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Oral Vaccines Product Portfolio
4.1.5 Merck Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Oral Vaccines Product Portfolio
4.2.5 GSK Recent Developments
4.3 Sanofi
4.3.1 Sanofi Company Information
4.3.2 Sanofi Business Overview
4.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sanofi Oral Vaccines Product Portfolio
4.3.5 Sanofi Recent Developments
4.4 Lanzhou Institute
4.4.1 Lanzhou Institute Company Information
4.4.2 Lanzhou Institute Business Overview
4.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
4.4.5 Lanzhou Institute Recent Developments
4.5 Serum Institute
4.5.1 Serum Institute Company Information
4.5.2 Serum Institute Business Overview
4.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Serum Institute Oral Vaccines Product Portfolio
4.5.5 Serum Institute Recent Developments
4.6 Valneva
4.6.1 Valneva Company Information
4.6.2 Valneva Business Overview
4.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Valneva Oral Vaccines Product Portfolio
4.6.5 Valneva Recent Developments
4.7 Shanghai United Cell
4.7.1 Shanghai United Cell Company Information
4.7.2 Shanghai United Cell Business Overview
4.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
4.7.5 Shanghai United Cell Recent Developments
4.8 Bibcol
4.8.1 Bibcol Company Information
4.8.2 Bibcol Business Overview
4.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Bibcol Oral Vaccines Product Portfolio
4.8.5 Bibcol Recent Developments
4.9 PaxVax
4.9.1 PaxVax Company Information
4.9.2 PaxVax Business Overview
4.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 PaxVax Oral Vaccines Product Portfolio
4.9.5 PaxVax Recent Developments
4.10 Vabiotech
4.10.1 Vabiotech Company Information
4.10.2 Vabiotech Business Overview
4.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Vabiotech Oral Vaccines Product Portfolio
4.10.5 Vabiotech Recent Developments
4.11 Tiantan Biological
4.11.1 Tiantan Biological Company Information
4.11.2 Tiantan Biological Business Overview
4.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Tiantan Biological Oral Vaccines Product Portfolio
4.11.5 Tiantan Biological Recent Developments
4.12 EuBiologics
4.12.1 EuBiologics Company Information
4.12.2 EuBiologics Business Overview
4.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.12.4 EuBiologics Oral Vaccines Product Portfolio
4.12.5 EuBiologics Recent Developments
4.13 Panacea Biotec Ltd
4.13.1 Panacea Biotec Ltd Company Information
4.13.2 Panacea Biotec Ltd Business Overview
4.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
4.13.5 Panacea Biotec Ltd Recent Developments
4.14 Bio-Med
4.14.1 Bio-Med Company Information
4.14.2 Bio-Med Business Overview
4.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Bio-Med Oral Vaccines Product Portfolio
4.14.5 Bio-Med Recent Developments
4.15 Halfkin Bio-Pharmaceuticals
4.15.1 Halfkin Bio-Pharmaceuticals Company Information
4.15.2 Halfkin Bio-Pharmaceuticals Business Overview
4.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
4.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
5 GLOBAL ORAL VACCINES MARKET SCENARIO BY REGION
5.1 Global Oral Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Oral Vaccines Sales by Region: 2019-2030
5.2.1 Global Oral Vaccines Sales by Region: 2019-2024
5.2.2 Global Oral Vaccines Sales by Region: 2025-2030
5.3 Global Oral Vaccines Revenue by Region: 2019-2030
5.3.1 Global Oral Vaccines Revenue by Region: 2019-2024
5.3.2 Global Oral Vaccines Revenue by Region: 2025-2030
5.4 North America Oral Vaccines Market Facts & Figures by Country
5.4.1 North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Oral Vaccines Sales by Country (2019-2030)
5.4.3 North America Oral Vaccines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Oral Vaccines Market Facts & Figures by Country
5.5.1 Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Oral Vaccines Sales by Country (2019-2030)
5.5.3 Europe Oral Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Oral Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific Oral Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Oral Vaccines Market Facts & Figures by Country
5.7.1 Latin America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Oral Vaccines Sales by Country (2019-2030)
5.7.3 Latin America Oral Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Oral Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Oral Vaccines Sales by Type (2019-2030)
6.1.1 Global Oral Vaccines Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Oral Vaccines Sales Market Share by Type (2019-2030)
6.2 Global Oral Vaccines Revenue by Type (2019-2030)
6.2.1 Global Oral Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global Oral Vaccines Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Oral Vaccines Sales by Application (2019-2030)
7.1.1 Global Oral Vaccines Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Oral Vaccines Sales Market Share by Application (2019-2030)
7.2 Global Oral Vaccines Revenue by Application (2019-2030)
7.2.1 Global Oral Vaccines Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
7.3 Global Oral Vaccines Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Oral Vaccines Value Chain Analysis
8.1.1 Oral Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oral Vaccines Production Mode & Process
8.2 Oral Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oral Vaccines Distributors
8.2.3 Oral Vaccines Customers
9 GLOBAL ORAL VACCINES ANALYZING MARKET DYNAMICS
9.1 Oral Vaccines Industry Trends
9.2 Oral Vaccines Industry Drivers
9.3 Oral Vaccines Industry Opportunities and Challenges
9.4 Oral Vaccines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Oral Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Oral Vaccines Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Oral Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Oral Vaccines Revenue of Manufacturers (2018-2023)
Table 9. Global Oral Vaccines Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Oral Vaccines Average Price (USD/K Doses) of Manufacturers (2018-2023)
Table 11. Global Oral Vaccines Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Oral Vaccines, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 19. Merck Oral Vaccines Product Portfolio
Table 20. Merck Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 24. GSK Oral Vaccines Product Portfolio
Table 25. GSK Recent Developments
Table 26. Sanofi Company Information
Table 27. Sanofi Business Overview
Table 28. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 29. Sanofi Oral Vaccines Product Portfolio
Table 30. Sanofi Recent Developments
Table 31. Lanzhou Institute Company Information
Table 32. Lanzhou Institute Business Overview
Table 33. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 34. Lanzhou Institute Oral Vaccines Product Portfolio
Table 35. Lanzhou Institute Recent Developments
Table 36. Serum Institute Company Information
Table 37. Serum Institute Business Overview
Table 38. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 39. Serum Institute Oral Vaccines Product Portfolio
Table 40. Serum Institute Recent Developments
Table 41. Valneva Company Information
Table 42. Valneva Business Overview
Table 43. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 44. Valneva Oral Vaccines Product Portfolio
Table 45. Valneva Recent Developments
Table 46. Shanghai United Cell Company Information
Table 47. Shanghai United Cell Business Overview
Table 48. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 49. Shanghai United Cell Oral Vaccines Product Portfolio
Table 50. Shanghai United Cell Recent Developments
Table 51. Bibcol Company Information
Table 52. Bibcol Business Overview
Table 53. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 54. Bibcol Oral Vaccines Product Portfolio
Table 55. Bibcol Recent Developments
Table 56. PaxVax Company Information
Table 57. PaxVax Business Overview
Table 58. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 59. PaxVax Oral Vaccines Product Portfolio
Table 60. PaxVax Recent Developments
Table 61. Vabiotech Company Information
Table 62. Vabiotech Business Overview
Table 63. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 64. Vabiotech Oral Vaccines Product Portfolio
Table 65. Vabiotech Recent Developments
Table 66. Tiantan Biological Company Information
Table 67. Tiantan Biological Business Overview
Table 68. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 69. Tiantan Biological Oral Vaccines Product Portfolio
Table 70. Tiantan Biological Recent Developments
Table 71. EuBiologics Company Information
Table 72. EuBiologics Business Overview
Table 73. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 74. EuBiologics Oral Vaccines Product Portfolio
Table 75. EuBiologics Recent Developments
Table 76. Panacea Biotec Ltd Company Information
Table 77. Panacea Biotec Ltd Business Overview
Table 78. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 79. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 80. Panacea Biotec Ltd Recent Developments
Table 81. Bio-Med Company Information
Table 82. Bio-Med Business Overview
Table 83. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 84. Bio-Med Oral Vaccines Product Portfolio
Table 85. Bio-Med Recent Developments
Table 86. Halfkin Bio-Pharmaceuticals Company Information
Table 87. Halfkin Bio-Pharmaceuticals Business Overview
Table 88. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 89. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 90. Halfkin Bio-Pharmaceuticals Recent Developments
Table 91. Global Oral Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Oral Vaccines Sales by Region (2018-2023) & (M Doses)
Table 93. Global Oral Vaccines Sales Market Share by Region (2018-2023)
Table 94. Global Oral Vaccines Sales by Region (2024-2029) & (M Doses)
Table 95. Global Oral Vaccines Sales Market Share by Region (2024-2029)
Table 96. Global Oral Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Oral Vaccines Revenue Market Share by Region (2018-2023)
Table 98. Global Oral Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Oral Vaccines Revenue Market Share by Region (2024-2029)
Table 100. North America Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 102. North America Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 103. North America Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 107. Europe Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 108. Europe Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 112. Asia Pacific Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 113. Asia Pacific Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 117. Latin America Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 118. Latin America Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 122. Middle East and Africa Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 123. Middle East and Africa Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Oral Vaccines Sales by Type (2018-2023) & (M Doses)
Table 126. Global Oral Vaccines Sales by Type (2024-2029) & (M Doses)
Table 127. Global Oral Vaccines Sales Market Share by Type (2018-2023)
Table 128. Global Oral Vaccines Sales Market Share by Type (2024-2029)
Table 129. Global Oral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Oral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Oral Vaccines Revenue Market Share by Type (2018-2023)
Table 132. Global Oral Vaccines Revenue Market Share by Type (2024-2029)
Table 133. Global Oral Vaccines Price by Type (2018-2023) & (USD/K Doses)
Table 134. Global Oral Vaccines Price by Type (2024-2029) & (USD/K Doses)
Table 135. Global Oral Vaccines Sales by Application (2018-2023) & (M Doses)
Table 136. Global Oral Vaccines Sales by Application (2024-2029) & (M Doses)
Table 137. Global Oral Vaccines Sales Market Share by Application (2018-2023)
Table 138. Global Oral Vaccines Sales Market Share by Application (2024-2029)
Table 139. Global Oral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Oral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Oral Vaccines Revenue Market Share by Application (2018-2023)
Table 142. Global Oral Vaccines Revenue Market Share by Application (2024-2029)
Table 143. Global Oral Vaccines Price by Application (2018-2023) & (USD/K Doses)
Table 144. Global Oral Vaccines Price by Application (2024-2029) & (USD/K Doses)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Oral Vaccines Distributors List
Table 148. Oral Vaccines Customers List
Table 149. Oral Vaccines Industry Trends
Table 150. Oral Vaccines Industry Drivers
Table 151. Oral Vaccines Industry Restraints
Table 152. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Oral Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Oral Vaccines Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Oral Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Oral Vaccines Revenue of Manufacturers (2018-2023)
Table 9. Global Oral Vaccines Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Oral Vaccines Average Price (USD/K Doses) of Manufacturers (2018-2023)
Table 11. Global Oral Vaccines Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Oral Vaccines, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 19. Merck Oral Vaccines Product Portfolio
Table 20. Merck Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 24. GSK Oral Vaccines Product Portfolio
Table 25. GSK Recent Developments
Table 26. Sanofi Company Information
Table 27. Sanofi Business Overview
Table 28. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 29. Sanofi Oral Vaccines Product Portfolio
Table 30. Sanofi Recent Developments
Table 31. Lanzhou Institute Company Information
Table 32. Lanzhou Institute Business Overview
Table 33. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 34. Lanzhou Institute Oral Vaccines Product Portfolio
Table 35. Lanzhou Institute Recent Developments
Table 36. Serum Institute Company Information
Table 37. Serum Institute Business Overview
Table 38. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 39. Serum Institute Oral Vaccines Product Portfolio
Table 40. Serum Institute Recent Developments
Table 41. Valneva Company Information
Table 42. Valneva Business Overview
Table 43. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 44. Valneva Oral Vaccines Product Portfolio
Table 45. Valneva Recent Developments
Table 46. Shanghai United Cell Company Information
Table 47. Shanghai United Cell Business Overview
Table 48. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 49. Shanghai United Cell Oral Vaccines Product Portfolio
Table 50. Shanghai United Cell Recent Developments
Table 51. Bibcol Company Information
Table 52. Bibcol Business Overview
Table 53. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 54. Bibcol Oral Vaccines Product Portfolio
Table 55. Bibcol Recent Developments
Table 56. PaxVax Company Information
Table 57. PaxVax Business Overview
Table 58. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 59. PaxVax Oral Vaccines Product Portfolio
Table 60. PaxVax Recent Developments
Table 61. Vabiotech Company Information
Table 62. Vabiotech Business Overview
Table 63. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 64. Vabiotech Oral Vaccines Product Portfolio
Table 65. Vabiotech Recent Developments
Table 66. Tiantan Biological Company Information
Table 67. Tiantan Biological Business Overview
Table 68. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 69. Tiantan Biological Oral Vaccines Product Portfolio
Table 70. Tiantan Biological Recent Developments
Table 71. EuBiologics Company Information
Table 72. EuBiologics Business Overview
Table 73. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 74. EuBiologics Oral Vaccines Product Portfolio
Table 75. EuBiologics Recent Developments
Table 76. Panacea Biotec Ltd Company Information
Table 77. Panacea Biotec Ltd Business Overview
Table 78. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 79. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 80. Panacea Biotec Ltd Recent Developments
Table 81. Bio-Med Company Information
Table 82. Bio-Med Business Overview
Table 83. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 84. Bio-Med Oral Vaccines Product Portfolio
Table 85. Bio-Med Recent Developments
Table 86. Halfkin Bio-Pharmaceuticals Company Information
Table 87. Halfkin Bio-Pharmaceuticals Business Overview
Table 88. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 89. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 90. Halfkin Bio-Pharmaceuticals Recent Developments
Table 91. Global Oral Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Oral Vaccines Sales by Region (2018-2023) & (M Doses)
Table 93. Global Oral Vaccines Sales Market Share by Region (2018-2023)
Table 94. Global Oral Vaccines Sales by Region (2024-2029) & (M Doses)
Table 95. Global Oral Vaccines Sales Market Share by Region (2024-2029)
Table 96. Global Oral Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Oral Vaccines Revenue Market Share by Region (2018-2023)
Table 98. Global Oral Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Oral Vaccines Revenue Market Share by Region (2024-2029)
Table 100. North America Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 102. North America Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 103. North America Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 107. Europe Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 108. Europe Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 112. Asia Pacific Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 113. Asia Pacific Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 117. Latin America Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 118. Latin America Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Oral Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Oral Vaccines Sales by Country (2018-2023) & (M Doses)
Table 122. Middle East and Africa Oral Vaccines Sales by Country (2024-2029) & (M Doses)
Table 123. Middle East and Africa Oral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Oral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Oral Vaccines Sales by Type (2018-2023) & (M Doses)
Table 126. Global Oral Vaccines Sales by Type (2024-2029) & (M Doses)
Table 127. Global Oral Vaccines Sales Market Share by Type (2018-2023)
Table 128. Global Oral Vaccines Sales Market Share by Type (2024-2029)
Table 129. Global Oral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Oral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Oral Vaccines Revenue Market Share by Type (2018-2023)
Table 132. Global Oral Vaccines Revenue Market Share by Type (2024-2029)
Table 133. Global Oral Vaccines Price by Type (2018-2023) & (USD/K Doses)
Table 134. Global Oral Vaccines Price by Type (2024-2029) & (USD/K Doses)
Table 135. Global Oral Vaccines Sales by Application (2018-2023) & (M Doses)
Table 136. Global Oral Vaccines Sales by Application (2024-2029) & (M Doses)
Table 137. Global Oral Vaccines Sales Market Share by Application (2018-2023)
Table 138. Global Oral Vaccines Sales Market Share by Application (2024-2029)
Table 139. Global Oral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Oral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Oral Vaccines Revenue Market Share by Application (2018-2023)
Table 142. Global Oral Vaccines Revenue Market Share by Application (2024-2029)
Table 143. Global Oral Vaccines Price by Application (2018-2023) & (USD/K Doses)
Table 144. Global Oral Vaccines Price by Application (2024-2029) & (USD/K Doses)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Oral Vaccines Distributors List
Table 148. Oral Vaccines Customers List
Table 149. Oral Vaccines Industry Trends
Table 150. Oral Vaccines Industry Drivers
Table 151. Oral Vaccines Industry Restraints
Table 152. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Oral VaccinesProduct Picture
Figure 5. Global Oral Vaccines Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Oral Vaccines Market Size (2018-2029) & (US$ Million)
Figure 7. Global Oral Vaccines Sales (2018-2029) & (M Doses)
Figure 8. Global Oral Vaccines Average Price (USD/K Doses) & (2018-2029)
Figure 9. Rotavirus Vaccine Product Picture
Figure 10. Cholera Vaccine Product Picture
Figure 11. Oral Polio Vaccine Product Picture
Figure 12. Public Product Picture
Figure 13. Private Product Picture
Figure 14. Global Oral Vaccines Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Oral Vaccines, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Oral Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Oral Vaccines Sales by Region in 2022
Figure 21. Global Oral Vaccines Revenue by Region in 2022
Figure 22. North America Oral Vaccines Market Size by Country in 2022
Figure 23. North America Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 24. North America Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Oral Vaccines Market Size by Country in 2022
Figure 28. Europe Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 29. Europe Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 30. Germany Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Oral Vaccines Market Size by Country in 2022
Figure 36. Asia Pacific Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 38. China Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Oral Vaccines Market Size by Country in 2022
Figure 48. Latin America Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 49. Latin America Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Oral Vaccines Market Size by Country in 2022
Figure 54. Middle East and Africa Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Oral Vaccines Sales Market Share by Type (2018-2029)
Figure 60. Global Oral Vaccines Revenue Market Share by Type (2018-2029)
Figure 61. Global Oral Vaccines Price (USD/K Doses) by Type (2018-2029)
Figure 62. Global Oral Vaccines Sales Market Share by Application (2018-2029)
Figure 63. Global Oral Vaccines Revenue Market Share by Application (2018-2029)
Figure 64. Global Oral Vaccines Price (USD/K Doses) by Application (2018-2029)
Figure 65. Oral Vaccines Value Chain
Figure 66. Oral Vaccines Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Oral Vaccines Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Oral VaccinesProduct Picture
Figure 5. Global Oral Vaccines Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Oral Vaccines Market Size (2018-2029) & (US$ Million)
Figure 7. Global Oral Vaccines Sales (2018-2029) & (M Doses)
Figure 8. Global Oral Vaccines Average Price (USD/K Doses) & (2018-2029)
Figure 9. Rotavirus Vaccine Product Picture
Figure 10. Cholera Vaccine Product Picture
Figure 11. Oral Polio Vaccine Product Picture
Figure 12. Public Product Picture
Figure 13. Private Product Picture
Figure 14. Global Oral Vaccines Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Oral Vaccines, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Oral Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Oral Vaccines Sales by Region in 2022
Figure 21. Global Oral Vaccines Revenue by Region in 2022
Figure 22. North America Oral Vaccines Market Size by Country in 2022
Figure 23. North America Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 24. North America Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Oral Vaccines Market Size by Country in 2022
Figure 28. Europe Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 29. Europe Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 30. Germany Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Oral Vaccines Market Size by Country in 2022
Figure 36. Asia Pacific Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 38. China Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Oral Vaccines Market Size by Country in 2022
Figure 48. Latin America Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 49. Latin America Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Oral Vaccines Market Size by Country in 2022
Figure 54. Middle East and Africa Oral Vaccines Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Oral Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Oral Vaccines Sales Market Share by Type (2018-2029)
Figure 60. Global Oral Vaccines Revenue Market Share by Type (2018-2029)
Figure 61. Global Oral Vaccines Price (USD/K Doses) by Type (2018-2029)
Figure 62. Global Oral Vaccines Sales Market Share by Application (2018-2029)
Figure 63. Global Oral Vaccines Revenue Market Share by Application (2018-2029)
Figure 64. Global Oral Vaccines Price (USD/K Doses) by Application (2018-2029)
Figure 65. Oral Vaccines Value Chain
Figure 66. Oral Vaccines Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Oral Vaccines Industry Opportunities and Challenges
